Atıf Formatları
Prognosis and Treatment for Active and Chronic Antibody-Mediated Rejection in Renal Transplant Recipients; Single Center Experience
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

V. T. Yilmaz Et Al. , "Prognosis and Treatment for Active and Chronic Antibody-Mediated Rejection in Renal Transplant Recipients; Single Center Experience," Transplantation Proceedings , vol.54, no.7, pp.1809-1815, 2022

Yilmaz, V. T. Et Al. 2022. Prognosis and Treatment for Active and Chronic Antibody-Mediated Rejection in Renal Transplant Recipients; Single Center Experience. Transplantation Proceedings , vol.54, no.7 , 1809-1815.

Yilmaz, V. T., Dandin, O., Kisaoglu, A., Avanaz, A., Kamaci, D., Toru, H. S., ... Demiryilmaz, I.(2022). Prognosis and Treatment for Active and Chronic Antibody-Mediated Rejection in Renal Transplant Recipients; Single Center Experience. Transplantation Proceedings , vol.54, no.7, 1809-1815.

Yilmaz, VURAL Et Al. "Prognosis and Treatment for Active and Chronic Antibody-Mediated Rejection in Renal Transplant Recipients; Single Center Experience," Transplantation Proceedings , vol.54, no.7, 1809-1815, 2022

Yilmaz, VURAL T. Et Al. "Prognosis and Treatment for Active and Chronic Antibody-Mediated Rejection in Renal Transplant Recipients; Single Center Experience." Transplantation Proceedings , vol.54, no.7, pp.1809-1815, 2022

Yilmaz, V. T. Et Al. (2022) . "Prognosis and Treatment for Active and Chronic Antibody-Mediated Rejection in Renal Transplant Recipients; Single Center Experience." Transplantation Proceedings , vol.54, no.7, pp.1809-1815.

@article{article, author={VURAL TANER YILMAZ Et Al. }, title={Prognosis and Treatment for Active and Chronic Antibody-Mediated Rejection in Renal Transplant Recipients; Single Center Experience}, journal={Transplantation Proceedings}, year=2022, pages={1809-1815} }